| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035851 Use of hmgb1 in the treatment of tissue damage and or to promote tissue repair |
| 02/16/2006 | US20060035847 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 02/16/2006 | US20060035844 Preventive or remedy for diseases caused by hyperglycemia |
| 02/16/2006 | US20060035840 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
| 02/16/2006 | US20060035836 Treatment of acute coronary syndrome with an exendin |
| 02/16/2006 | US20060035326 Genes |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035268 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 02/16/2006 | US20060034951 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/16/2006 | US20060034949 Remedy |
| 02/16/2006 | US20060034896 triglycerides such as triester of caprylic acid or capric acid with glycerin, used along with foods or drugs, without concerning about side effects and restrictive diets |
| 02/16/2006 | US20060034892 Composition for topical administration |
| 02/16/2006 | US20060034863 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 02/16/2006 | US20060034832 Cell death inhibitor |
| 02/16/2006 | US20060034826 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 02/16/2006 | US20060034799 Tissue protective cytokines for the protection, restoration, and enhancement fo responsive cells, tissues and organs |
| 02/16/2006 | CA2576405A1 Antibody and utilization of the same |
| 02/16/2006 | CA2575907A1 Novel uses of 2-phenyl-substituted imidazotriazinone derivatives |
| 02/16/2006 | CA2575039A1 Novel cyclic amino benzoic acid derivative |
| 02/16/2006 | CA2575014A1 Crp lowering agent |
| 02/15/2006 | EP1626056A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity |
| 02/15/2006 | EP1626049A1 Microcrystal |
| 02/15/2006 | EP1626048A1 Crystal of benzimidazole derivative and process for producing the same |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1453835B1 Adenosine a 2a receptor antagonists |
| 02/15/2006 | EP1399468B1 2-((n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl)-amino)-alkylboronic acid derivatives |
| 02/15/2006 | EP1341533B1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 02/15/2006 | EP1268493B1 Phosphoramidate prodrugs |
| 02/15/2006 | EP1224207B1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 02/15/2006 | EP1154767B1 Substituted stilbene compounds with vascular damaging activity |
| 02/15/2006 | EP1076562B1 Glucocorticoid receptor antagonists for the treatment of dementia |
| 02/15/2006 | EP1041985B1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1735435A Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 02/15/2006 | CN1735423A Treatment of gastroparesis |
| 02/15/2006 | CN1735416A Therapeutic combination |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735414A Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 02/15/2006 | CN1735407A Methods of using and compositions comprising dopamine reuptake inhibitors |
| 02/15/2006 | CN1735400A Drug delivery system using subconjunctival depot |
| 02/15/2006 | CN1735344A Novel substituted benzimidazole dosage forms and method of using same |
| 02/15/2006 | CN1733761A Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and the use thereof in the production of a medicament |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
| 02/15/2006 | CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/15/2006 | CN1733699A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 02/15/2006 | CN1733307A Antihypertensive combination of valsartan and calcium channel blocker |
| 02/15/2006 | CN1733296A Stable liquid interferon formulations |
| 02/15/2006 | CN1733293A Cerebroside carnosine freeze-dried powder and process for preparing the same |
| 02/15/2006 | CN1733249A Health caring oral liquid capable of postponing senility |
| 02/15/2006 | CN1733244A Chinese traditional medicine composition for relieving side effects of hormones |
| 02/15/2006 | CN1733186A Externally used medicine for curing acute or chronic soft tissue injury and process for preparing the same |
| 02/15/2006 | CN1733131A Schisandra fruit extractive, its preparation process and purposes |
| 02/15/2006 | CN1733035A Anti-fatigue health products and its preparation method |
| 02/15/2006 | CN1733034A Anti-fatigue pine pollen tablet |
| 02/15/2006 | CN1732991A Process for preparing capsule for treating urination difficulty |
| 02/15/2006 | CN1732974A Medicinal composition of fructose diphosphate sodium and magnesium salt |
| 02/15/2006 | CN1732961A Gallotannins and ellagitannins as regulators of cytokine release |
| 02/15/2006 | CN1732946A Pharmaceutical composition for preventing and treating poultry ascites |
| 02/15/2006 | CN1732941A Compound medicine for treating meat chicken ascites |
| 02/15/2006 | CN1732923A Ligustilide cyclodextrin or its derivatives clathrate, its preparation method and pharmaceutical formulation |
| 02/15/2006 | CN1732922A Soft capsule of cis form ligustilide |
| 02/15/2006 | CN1732914A In-vivo oxygen supplying solution for injection and its preparation process |
| 02/15/2006 | CN1242045C Method for making compound wine containing xylitol, ginseng, colla os cervi and tortoise plastron glue |
| 02/15/2006 | CN1241945C Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |
| 02/15/2006 | CN1241925C New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 02/15/2006 | CN1241912C Disulfide derivatives useful for treating allergic diseases |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/15/2006 | CN1241907C Organic compounds |
| 02/15/2006 | CN1241901C Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method |
| 02/15/2006 | CN1241638C IFNAR2/I FN complex |
| 02/15/2006 | CN1241636C Treatment of epidermlyosis bullosa with thymosin Beta-4 |
| 02/15/2006 | CN1241616C Aloe and ant capsule |
| 02/15/2006 | CN1241583C Fermented soybean extracted liquid and composite medicine containing the said liquid |
| 02/15/2006 | CN1241575C Cell growth regulating factor U and its preparation process |
| 02/15/2006 | CN1241573C Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoismerase I and topoismerase II inhibitors |
| 02/15/2006 | CN1241569C Novel combination of non sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjuncitivitis |
| 02/15/2006 | CN1241545C Pharmaceutical composition |
| 02/15/2006 | CN1241534C Cosmetic skin care compositions containing cumic alcohol |
| 02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 02/14/2006 | US6998422 Using pravastatin mixture with taurine, panthethine and inosiutol and hexanicotinate; anticholesterol agent, cardiovascular disorders |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/14/2006 | US6998403 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia |
| 02/14/2006 | US6998402 7-(1-Acetylpentyl)-5-methyl-2-(4-methylbenzyl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one; learning enhancement, concentration power, learning power, memory power; enzyme inhibitors of phosphodiesterase isoenzyme |
| 02/14/2006 | US6998401 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins |
| 02/14/2006 | US6998395 Controlled release formulation for preventing or treating risk factors for cardiovascular disease |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | US6998244 contacting a cell transformed or transfected with an expression vector capable of expressing 5-HT4 receptor with a compound in presence of a ligand, monitoring CAMP formation in the cell, a change indicates compund as an antagonist or agonist |
| 02/14/2006 | US6998238 Method for determining MIF content |
| 02/14/2006 | US6998231 Coding or classification of prion sample; obtain sample, monitor physical properties of sample, compare to control |
| 02/14/2006 | US6998136 Stability for injection solutions |
| 02/14/2006 | US6998129 Comprises association between elastase inhibitor compound of the N-acylaminoamide family and at least one antiinflammatory compound; for improving skin ageing and/or photoageing signs by slowing down connective tissue alterations |
| 02/14/2006 | US6998125 Administering a cytotoxic T-lymphocyte and one agent capable of neutralizing or down regulating the activity of tumor secreted immunosuppressive factors |
| 02/14/2006 | US6998123 interleukins (IL-11); fibronectins; glycoproteins |